approved EB-2 (NIW)

Research Fellow

Immunology · Nepal · 2022-03-07

Processing Time
110 days
Decision Date
2022-03-07
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research on uncovering the cellular and molecular mechanisms of disease progression to improve treatment options and health outcomes for people living with autoimmune and allergic diseases. His work specifically focuses on the screening of synthetic compounds for the treatment of autoimmune and inflammatory conditions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses pressing global health concerns regarding the prevalence and treatment of autoimmune diseases.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., 14 publications, 155 citations, and peer review experience demonstrate his reliability and expertise in the field.

3 Waiver Benefit Met

The petitioner's work in advancing therapeutic treatments for inflammatory diseases justifies a waiver of the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in pharmacy and his record of 14 peer-reviewed journal articles which garnered 155 citations. Additional evidence included 3 completed peer reviews for scientific journals and research funding from the National Research Foundation of Korea, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions

Similar Cases

Software Engineer

Artificial Intelligence · India

WeGreened EB-2 (NIW) approved
California 111 days 2026-12-13
The petitioner proposes to develop AI-driven activity monitoring methods for quality assurance in large-scale digital systems. The work focuses on identifying risks earlier and improving reliability to reduce costly disruptions across complex software platforms.

Management Consultant

Information Technology

WeGreened EB-2 (NIW) approved
2026-03-15
The petitioner proposes to continue their work in enterprise technology transformation, governance, and large-scale operational strategy. The work focuses on enhancing enterprise resilience, cybersecurity alignment, and digital transformation within major organizations to improve high-stakes operational settings.

Researcher

Healthcare

WeGreened EB-2 (NIW) approved
3 days 2026-03-02
The petitioner proposes to combine advanced clinical training with research to improve minimally invasive and reconstructive approaches for complex facial and nerve injuries. The work focuses on reducing downstream functional impairment and the overall care burden for patients.

Others

Information Technology · China

WeGreened EB-2 (NIW) approved
317 days 2026-02-21
The petitioner proposes to develop advanced deep learning models to improve the understanding of structure-function relationships in large biomolecules. This work aims to enable more accurate target identification, better candidate design, and more efficient therapeutic optimization for complex diseases. The endeavor specifically targets bottlenecks in drug development to reduce the high failure rate and cost of new drug candidates.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 110 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist